The orexin system: a link between addiction and depression

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1072706

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Relapse represents the most significant barrier to the successful treatment of addiction Interestingly, relapse rates are significantly higher amongst addicts with a concurrent mood disorder such as depression. This fellowship will use a number of cutting-edge techniques to explore the role of a hypothalamic peptide called 'orexin' in both relapse and depression and will thereby guide translational research aimed at developing pharmacotherapies designed to treat these disorders.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $378,426.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Central Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

addiction | animal model | depression | hypothalamus | neural pathways | neuropeptides | relapse

Related Links